Does LANADELUMAB-FLYO Cause Neoplasm malignant? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Neoplasm malignant have been filed in association with LANADELUMAB-FLYO. This represents 0.7% of all adverse event reports for LANADELUMAB-FLYO.
11
Reports of Neoplasm malignant with LANADELUMAB-FLYO
0.7%
of all LANADELUMAB-FLYO reports
0
Deaths
7
Hospitalizations
How Dangerous Is Neoplasm malignant From LANADELUMAB-FLYO?
Of the 11 reports, 7 (63.6%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LANADELUMAB-FLYO. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does LANADELUMAB-FLYO Cause?
Hereditary angioedema (794)
Product dose omission issue (177)
Inappropriate schedule of product administration (144)
Drug ineffective (137)
Headache (126)
Weight decreased (125)
Weight increased (120)
Injection site pain (119)
Product use issue (114)
Malaise (90)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which LANADELUMAB-FLYO Alternatives Have Lower Neoplasm malignant Risk?
LANADELUMAB-FLYO vs LANREOTIDE
LANADELUMAB-FLYO vs LANSOPRAZOLE
LANADELUMAB-FLYO vs LANTHANUM
LANADELUMAB-FLYO vs LANTUS
LANADELUMAB-FLYO vs LANTUS SOLOSTAR